Micaela Bayard, MD

Bayard is a rheumatologist at Mount Sinai and assistant professor of rheumatology at The Icahn School of Medicine.

Most recent by Micaela Bayard, MD

SPONSORED CONTENT
December 06, 2024
2 min watch
Save

VIDEO: ACR ‘empowering’ next generation with Women in Rheumatology task force

WASHINGTON — In this video, Micaela F. Bayard, MD, shares her partnership and involvement with The Lupus and Allied Diseases Association and the Women in Rheumatology Task Force.

SPONSORED CONTENT
December 05, 2024
2 min watch
Save

VIDEO: Emerging role of AI in rheumatology

WASHINGTON — Healio speaks with Micaela F. Bayard, MD, about AI and its integration into clinical practice for rheumatologists.

SPONSORED CONTENT
December 05, 2024
2 min watch
Save

VIDEO: Bringing patient voices to the forefront in rheumatoid arthritis clinical trials

WASHINGTON — In this video, Micaela F. Bayard, MD, discusses the shift at major conferences to include patients voices and perspectives.

SPONSORED CONTENT
December 04, 2024
3 min watch
Save

VIDEO: Improving steroid management in rheumatoid arthritis

WASHINGTON —Micaela F. Bayard, MD, spoke with Healio about the management of steroids and how this topic was covered at ACR Convergence 2024.

SPONSORED CONTENT
December 04, 2024
2 min watch
Save

VIDEO: Biosimilar use, education highlighted at ACR

WASHINGTON — In this video, Micaela F. Bayard, MD, highlights a conversation on the evolution of biosimilars from ACR Convergence 2024.

SPONSORED CONTENT
June 24, 2024
1 min watch
Save

VIDEO: Future research on JAK inhibitors should focus on personalized medicine

SPONSORED CONTENT
June 24, 2024
2 min watch
Save

VIDEO: Risk stratification key before prescribing JAK inhibitors

SPONSORED CONTENT
June 24, 2024
2 min watch
Save

VIDEO: JAK inhibitors may enable management of multiple autoimmune diseases with less medication

SPONSORED CONTENT
June 19, 2024
1 min watch
Save

VIDEO: New indications for JAK inhibitors advance field

SPONSORED CONTENT
June 24, 2024
2 min watch
Save

VIDEO: Benefit of switching JAK inhibitors before trying injectable, infusion therapy